Healthcare provider profile · identity verified

Heidy Cecilia Ormeno Lopez, M.D.

Internal Medicine · WINTER SPRINGS, FL · NPI 1851555759

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	628	232
Atorvastatin Calcium	Atorvastatin Calcium	620	249
Losartan Potassium	Losartan Potassium	402	151
Levothyroxine Sodium	Levothyroxine Sodium	331	129
Lisinopril	Lisinopril	280	113
Omeprazole	Omeprazole	250	104
Metformin Hcl	Metformin Hcl	248	104
Gabapentin	Gabapentin	205	91
Albuterol Sulfate Hfa	Albuterol Sulfate	204	71
Metoprolol Tartrate	Metoprolol Tartrate	195	69
Simvastatin	Simvastatin	175	77
Hydrochlorothiazide	Hydrochlorothiazide	153	55
Pantoprazole Sodium	Pantoprazole Sodium	152	68
Potassium Chloride	Potassium Chloride	141	43
Rosuvastatin Calcium	Rosuvastatin Calcium	138	61
Furosemide	Furosemide	132	50
Eliquis	Apixaban	130	40
Tamsulosin Hcl	Tamsulosin Hcl	129	54
Tizanidine Hcl	Tizanidine Hcl	120	43
Pravastatin Sodium	Pravastatin Sodium	117	45
Vitamin D2	Ergocalciferol (Vitamin D2)	111	37
Alprazolam	Alprazolam	109	21
Metoprolol Succinate	Metoprolol Succinate	107	45
Hydralazine Hcl	Hydralazine Hcl	106	41
Clonidine Hcl	Clonidine Hcl	103	42
Ozempic	Semaglutide	101	22
Diclofenac Sodium	Diclofenac Sodium	100	53
Trazodone Hcl	Trazodone Hcl	100	42
Clopidogrel	Clopidogrel Bisulfate	97	39
Allopurinol	Allopurinol	96	37
Tramadol Hcl	Tramadol Hcl	90	26
Alendronate Sodium	Alendronate Sodium	82	36
Fluticasone Propionate	Fluticasone Propionate	81	40
Montelukast Sodium	Montelukast Sodium	75	27
Trulicity	Dulaglutide	75	21
Carvedilol	Carvedilol	73	35
Baclofen	Baclofen	71	32
Famotidine	Famotidine	69	30
Meloxicam	Meloxicam	65	26
Donepezil Hcl	Donepezil Hcl	62	22
Metformin Hcl Er	Metformin Hcl	60	23
Buspirone Hcl	Buspirone Hcl	59	18
Ezetimibe	Ezetimibe	58	27
Prednisone	Prednisone	58	43
Lovastatin	Lovastatin	55	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	20
Glimepiride	Glimepiride	52	22
Duloxetine Hcl	Duloxetine Hcl	51	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	12
Atenolol	Atenolol	46	17
Meclizine Hcl	Meclizine Hcl	46	25
Lorazepam	Lorazepam	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	15
Mounjaro	Tirzepatide	44	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	19
Escitalopram Oxalate	Escitalopram Oxalate	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	16
Bumetanide	Bumetanide	39	11
Pioglitazone Hcl	Pioglitazone Hcl	38	16
Finasteride	Finasteride	37	14
Citalopram Hbr	Citalopram Hydrobromide	36	16
Sertraline Hcl	Sertraline Hcl	36	16
Azithromycin	Azithromycin	35	33
Novolin N	Insulin Nph Human Isophane	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	24
Doxazosin Mesylate	Doxazosin Mesylate	32	14
Synthroid	Levothyroxine Sodium	32	suppressed
Tradjenta	Linagliptin	32	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Jardiance	Empagliflozin	31	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	13
Warfarin Sodium	Warfarin Sodium	31	suppressed
Methocarbamol	Methocarbamol	30	15
Novolog Flexpen	Insulin Aspart	30	suppressed
Valsartan	Valsartan	30	15
Doxycycline Monohydrate	Doxycycline Monohydrate	29	26
Mirtazapine	Mirtazapine	29	12
Hydroxyzine Hcl	Hydroxyzine Hcl	27	13
Methylprednisolone	Methylprednisolone	26	24
Lactulose	Lactulose	25	suppressed
Fenofibrate	Fenofibrate	24	11
Glipizide Er	Glipizide	24	12
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	12
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Colchicine	Colchicine	22	suppressed
Spironolactone	Spironolactone	21	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Nystatin	Nystatin	20	11
Cephalexin	Cephalexin	19	16
Novolin R	Insulin Regular, Human	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Linzess	Linaclotide	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Terazosin Hcl	Terazosin Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	17
Fluconazole	Fluconazole	17	12
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Glipizide	Glipizide	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	13
Hydrocortisone	Hydrocortisone	14	suppressed
Ibuprofen	Ibuprofen	14	11
Labetalol Hcl	Labetalol Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prolia	Denosumab	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Lidocaine	Lidocaine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error